Dortmund Fertility Centre, 44135 Dortmund, Germany.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Witten/Herdecke University, 44135 Dortmund, Germany.
Int J Mol Sci. 2023 Jul 4;24(13):11061. doi: 10.3390/ijms241311061.
Ovarian tissue cryopreservation (OTC) or testicular tissue cryopreservation (TTC) are effective and often the only options for fertility preservation in female or male patients due to oncological, medical, or social aspects. While TTC and resumption of spermatogenesis, either in vivo or in vitro, has still be considered an experimental approach in humans, OTC and autotransplantation has been applied increasingly to preserve fertility, with more than 200 live births worldwide. However, the cryopreservation of reproductive cells followed by the resumption of gametogenesis, either in vivo or in vitro, may interfere with sensitive and highly regulated cellular processes. In particular, the epigenetic profile, which includes not just reversible modifications of the DNA itself but also post-translational histone modifications, small non-coding RNAs, gene expression and availability, and storage of related proteins or transcripts, have to be considered in this context. Due to complex reprogramming and maintenance mechanisms of the epigenome in germ cells, growing embryos, and offspring, OTC and TTC are carried out at very critical moments early in the life cycle. Given this background, the safety of OTC and TTC, taking into account the epigenetic profile, has to be clarified. Cryopreservation of mature germ cells (including metaphase II oocytes and mature spermatozoa collected via ejaculation or more invasively after testicular biopsy) or embryos has been used successfully for many years in medically assisted reproduction (MAR). However, tissue freezing followed by in vitro or in vivo gametogenesis has become more attractive in the past, while few human studies have analysed the epigenetic effects, with most data deriving from animal studies. In this review, we highlight the potential influence of the cryopreservation of immature germ cells and subsequent in vivo or in vitro growth and differentiation on the epigenetic profile (including DNA methylation, post-translational histone modifications, and the abundance and availability of relevant transcripts and proteins) in humans and animals.
卵巢组织冷冻保存(OTC)或睾丸组织冷冻保存(TTC)是有效的,并且由于肿瘤学、医学或社会方面的原因,通常是女性或男性患者进行生育力保存的唯一选择。虽然 TTC 和精子发生的恢复,无论是体内还是体外,在人类中仍被认为是一种实验方法,但 OTC 和自体移植已被越来越多地应用于生育力的保存,全世界已有 200 多个活产。然而,生殖细胞的冷冻保存,随后无论是体内还是体外,配子发生的恢复,可能会干扰敏感和高度调控的细胞过程。特别是表观遗传谱,它不仅包括 DNA 本身的可逆修饰,还包括翻译后组蛋白修饰、小非编码 RNA、基因表达和可用性以及相关蛋白质或转录本的储存,在这种情况下必须考虑到这一点。由于生殖细胞、胚胎和后代中表观基因组的复杂重编程和维持机制,OTC 和 TTC 是在生命周期的早期非常关键的时刻进行的。鉴于此,必须澄清 OTC 和 TTC 的安全性,同时考虑到表观遗传谱。成熟生殖细胞(包括减数分裂 II 期卵母细胞和通过射精或睾丸活检后更具侵入性收集的成熟精子)或胚胎的冷冻保存已在医学辅助生殖(MAR)中成功使用多年。然而,过去组织冷冻保存后体外或体内配子发生变得更具吸引力,而很少有人类研究分析了表观遗传效应,大多数数据来自动物研究。在这篇综述中,我们强调了不成熟生殖细胞的冷冻保存以及随后的体内或体外生长和分化对人类和动物中表观遗传谱(包括 DNA 甲基化、翻译后组蛋白修饰以及相关转录本和蛋白质的丰度和可用性)的潜在影响。